Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:47 PM
Ignite Modification Date:
2025-12-24 @ 6:47 PM
NCT ID:
NCT01903057
Eligibility Criteria:
Inclusion Criteria:
* Age ≥ 5 years and ≤ 65 years.
* Height ≥ 90 cm
* Able to understand the information and consent and assent forms, willing to give consent and assent, and abide by the study restrictions (parent or guardian consent if study participant age is \< 18 years, participant to assent form if age \< 18 years and ≥ 7 years)
* Residence in the study site for at least three months prior to enrolment
* Willing to remain in the study site for the duration of the study
* Willing and able to provide necessary samples to permit evaluation.
Exclusion Criteria:
* Unable to swallow tablets
* History of hypersensitivity/allergy to azithromycin, ivermectin, and/or albendazole
* Treatment with another investigational agent/intervention within 4 weeks prior to study entry
* Pregnancy (demonstrated by positive urine pregnancy test, performed by study staff, or evidently pregnant). All women of child bearing age (≥ 12 years and ≤ 49 years in Nampula province, personal communication, Arlinda Martins) will undergo a urine pregnancy test (unless they are evidently pregnant) to exclude pregnancy.
* Breast-feeding mother.
* Any condition that, in the opinion of the investigator, might interfere with the outcome of the study and/or adherence to the follow up schedule, such as clinically significant illness.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
5 Years
Maximum Age:
65 Years
Study:
NCT01903057
Study Brief:
Protocol Section:
NCT01903057